Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,400,871
+$99,535 QoQ
Shares Held
904,078
+15.1% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,358,401 | $5,227,597,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,211,475 | $3,355,318,297 | |
| 3 | ABBV |
AbbVie Inc.
|
8,163,806 | $2,054,340,133 | |
| 4 | AZN |
Astrazeneca PLC
|
10,427,503 | $1,977,263,112 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,293,086 | $1,836,661,547 | |
| 6 | AMGN |
Amgen Inc
|
4,328,785 | $1,567,539,618 | |
| 7 | PFE |
Pfizer Inc
|
32,814,260 | $790,167,373 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,094,886 | $696,907,326 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,400,871 | 904,078 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,301,336 | 785,703 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,365,972 | 680,853 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,457,092 | 547,901 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,582,120 | 506,872 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $3,461,317 | 486,824 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $2,976,414 | 400,056 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,754,550 | 422,810 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,231,473 | 353,641 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $1,686,070 | 252,406 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $2,963,428 | 256,352 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,287,594 | 250,284 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,393,717 | 261,323 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,934,292 | 262,455 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,267,935 | 266,816 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,556,242 | 252,637 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,441,564 | 289,694 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,429,760 | 293,644 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,780,389 | 247,586 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,680,111 | 251,890 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,879,097 | 338,853 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,978,150 | 230,084 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $3,539,741 | 191,960 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,940,631 | 111,852 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,890,428 | 103,642 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,836,142 | 91,169 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||